Literature DB >> 11801899

Respiratory bronchiolitis-associated interstitial lung disease: radiologic features with clinical and pathologic correlation.

Jai Soung Park1, Kevin K Brown, Rubin M Tuder, Valerie A E Hale, Talmadge E King, David A Lynch.   

Abstract

PURPOSE: The purpose of this work was to describe the radiographic and CT findings in patients with respiratory bronchiolitis-associated interstitial lung disease (RB-ILD) and to correlate them with clinical, physiologic, and pathologic features.
METHOD: RB-ILD was proved pathologically in all 21 patients. Sixteen (76%) patients were current smokers, and five (24%) patients were ex-smokers. The mean cigarette consumption was 38.7 pack-years. Chest radiographs and CT scans were semiquantitatively analyzed and correlated with clinical findings, physiologic measures, and a pathologic score of disease extent.
RESULTS: The major radiographic findings were bronchial wall thickening in 16 patients (76%) and ground-glass opacity in 12 patients (57%). The predominant initial CT findings were central bronchial wall thickening (proximal to subsegmental bronchi) in 19 patients (90%), peripheral bronchial wall thickening (distal to subsegmental bronchi) in 18 patients (86%), centrilobular nodules in 15 patients (71%), and ground-glass opacity in 14 patients (67%), None of these CT findings had a significant zonal predominance. Other findings were upper lung predominant centrilobular emphysema (57%) and patchy areas of hypoattenuation (38%) with a lower lung predominance. Radiologic findings were similar in both current and ex-smokers. The amount of ground-glass opacity correlated inversely with arterial oxygen saturation ( r = -0.67, p = 0.04), and the areas of hypoattenuation correlated with alveolar-arterial oxygen gradient ( r = 0.56, p = 0.04). The extent of centrilobular nodules correlated with the extent of macrophages in respiratory bronchioles ( r = 0.53, p = 0.03) and with chronic inflammation of respiratory bronchioles ( r = 0.57, p = 0.02). The extent of ground-glass opacity correlated with the amount of macrophage accumulation in the alveoli and alveolar ducts ( r = 0.56, p < 0.01 and r = 0.54, p = 0.04, respectively). At follow-up CT after steroid treatment and smoking cessation, in nine patients, the extent of bronchial wall thickening, centrilobular nodules, and ground-glass opacity had decreased, but the areas of hypoattenuation had increased (p < 0.05).
CONCLUSION: The CT findings of RB-ILD are centrilobular nodules, ground-glass opacity, and air trapping. These radiologic features, in patients with a history of heavy cigarette smoking, may differentiate RB-ILD from other interstitial lung diseases.

Entities:  

Mesh:

Year:  2002        PMID: 11801899     DOI: 10.1097/00004728-200201000-00003

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  17 in total

1.  The "dirty chest"--correlations between chest radiography, multislice CT and tobacco burden.

Authors:  J Kirchner; J P Goltz; F Lorenz; A Obermann; E M Kirchner; R Kickuth
Journal:  Br J Radiol       Date:  2011-09-21       Impact factor: 3.039

Review 2.  Challenges in pulmonary fibrosis. 1: Use of high resolution CT scanning of the lung for the evaluation of patients with idiopathic interstitial pneumonias.

Authors:  Michael B Gotway; Michelle M Freemer; Talmadge E King
Journal:  Thorax       Date:  2007-06       Impact factor: 9.139

Review 3.  Pulmonary function testing in idiopathic interstitial pneumonias.

Authors:  Fernando J Martinez; Kevin Flaherty
Journal:  Proc Am Thorac Soc       Date:  2006-06

4.  CT-Definable Subtypes of Chronic Obstructive Pulmonary Disease: A Statement of the Fleischner Society.

Authors:  David A Lynch; John H M Austin; James C Hogg; Philippe A Grenier; Hans-Ulrich Kauczor; Alexander A Bankier; R Graham Barr; Thomas V Colby; Jeffrey R Galvin; Pierre Alain Gevenois; Harvey O Coxson; Eric A Hoffman; John D Newell; Massimo Pistolesi; Edwin K Silverman; James D Crapo
Journal:  Radiology       Date:  2015-05-11       Impact factor: 11.105

5.  Fibrinogen mediates cadmium-induced macrophage activation and serves as a predictor of cadmium exposure in chronic obstructive pulmonary disease.

Authors:  Fu Jun Li; Ranu Surolia; Pooja Singh; Kevin G Dsouza; Crystal T Stephens; Zheng Wang; Rui-Ming Liu; Sejong Bae; Young-Il Kim; Mohammad Athar; Mark T Dransfield; Veena B Antony
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2022-02-24       Impact factor: 5.464

6.  High-resolution CT findings of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.

Authors:  Martin L D Gunn; J David Godwin; Jeffrey P Kanne; Mary E Flowers; Jason W Chien
Journal:  J Thorac Imaging       Date:  2008-11       Impact factor: 3.000

Review 7.  Challenges in pulmonary fibrosis . 4: smoking-induced diffuse interstitial lung diseases.

Authors:  Athol U Wells; Andrew G Nicholson; David M Hansell
Journal:  Thorax       Date:  2007-10       Impact factor: 9.139

Review 8.  Smoking-related lung abnormalities on computed tomography images: comparison with pathological findings.

Authors:  Tae Iwasawa; Tamiko Takemura; Takashi Ogura
Journal:  Jpn J Radiol       Date:  2017-12-15       Impact factor: 2.374

9.  Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate.

Authors:  Gong Yong Jin; David Lynch; Ashish Chawla; Kavita Garg; Martin C Tammemagi; Hakan Sahin; Shigeki Misumi; Keun Sang Kwon
Journal:  Radiology       Date:  2013-03-19       Impact factor: 11.105

10.  Lung volumes and emphysema in smokers with interstitial lung abnormalities.

Authors:  George R Washko; Gary M Hunninghake; Isis E Fernandez; Mizuki Nishino; Yuka Okajima; Tsuneo Yamashiro; James C Ross; Raúl San José Estépar; David A Lynch; John M Brehm; Katherine P Andriole; Alejandro A Diaz; Ramin Khorasani; Katherine D'Aco; Frank C Sciurba; Edwin K Silverman; Hiroto Hatabu; Ivan O Rosas
Journal:  N Engl J Med       Date:  2011-03-10       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.